Navigation Links
Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
Date:4/5/2011

NEW YORK, April 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Leading Anti-Cancer Drugs: World Market Prospects 2011-2021

http://www.reportlinker.com/p0470103/Leading-Anti-Cancer-Drugs-World-Market-Prospects-2011-2021.html

What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now.

What revenues will cancer treatment markets generate from 2011 to 2021? What gains will leading companies and products achieve? What sales trends will leading national markets - developed and developing - show?

Our study answers those questions and many others for anti-cancer agents. By ordering now, you can stay ahead. We aim to save you time and aid your decisions.

Anti-cancer drug sales exceeded $50bn worldwide in 2009, with impressive growth. Our report shows you where cancer therapies are heading from 2011 to 2021 - technology, competition and revenues. 

Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in 2008 (WHO). We show the potential for cancer treatments, existing and in development. 

Our report shows you revenue forecasts at total world, sub-market, product and national levels. You can assess the potential of the anti-cancer drug industry and market now.

We show the industry's strengths, weaknesses, trends and opportunities from 2011. We show you oncology R&D trends - pipeline and emerging treatments to look out for.

In our repor
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
2. Reportlinker Adds World Anti-Obesity Drug Market 2011-2021
3. Reportlinker Adds World Biological Drugs Market 2011-2021
4. Reportlinker Adds World Influenza Vaccines Market 2011-2021
5. Reportlinker Adds Drug Delivery in Cancer - technologies, markets and companies
6. Reportlinker Adds Enzymes in Drug Manufacturing
7. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
8. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
9. Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing
10. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
11. Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Many ... Undoubtedly, the growing influence of patients in the ... marketing interactions. Now, more than ever, understanding how ... for medical products is essential. ... Practices, LLC, benchmarked companies spent about two-thirds of ...
(Date:11/21/2014)... and VIENNA, Va. , ... in-home care provider that operates in Southern ... leading provider of remote caregiving technology. Alta will be ... existing client receiving homecare services. Logo - ... technology is the key to providing the kind of ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... Dec. 12, 2011 /PRNewswire-iReach/ -- Reagent ... a common compliance concern driving Quality Control departments ... VerGo Pharma Research proves to be an innovative ... their business practices this month.  Harness ...
... Phase III clinical trial data presented today contribute ... Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in ... have deeper levels of response compared to those ... The findings from the ENEST (Evaluating Nilotinib Efficacy ...
Cached Medicine Technology:VerGo Integrates New Solution for Tracking Compliance Dates 2Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 2Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 3Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 4Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 5Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 6Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 7Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 8Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 9Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 10Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 11Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 12Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 13Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 14Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 15Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 16
(Date:11/24/2014)... Diego, California (PRWEB) November 24, 2014 Dr. ... San Diego Fertility Center, recently appeared on NBC to discuss ... option. Egg freezing has been trending in the news recently, ... this expensive procedure for women. , “[The companies] ... women who are on a career hot path.” Says Dr. ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Nearly ... heart attacks, strokes, deep vein thrombosis and other ... a federal multidistrict litigation (MDL) underway in the ... , Court documents updated on November 17th ... (JPML) show the filing of 259 lawsuits against ...
(Date:11/23/2014)... November 23, 2014 This evaluation ... as its significance, programs and manufacturing technological innovation. ... suppliers major market gamers in information. In this ... specifications, prospective, manufacturing value, and 2009-2014 market shares ... evaluation symbolizes the globally and Chinese suppliers finish ...
(Date:11/23/2014)... 2014 AngelWeddingDress.com has recently ... selection of beach wedding dresses. “If you are looking ... AngelWeddingDress.com as soon as possible. Here you can enjoy ... manager says. , Holding a big marriage ceremony is ... a beautiful beach wedding dress is uppermost priority. Ophelia, ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2
... , ... Boston (Vocus) October 10, 2008 -- Several ... presenting at the 2008 American Academy of Pediatrics National Conference and ... and topics are listed below. , , Pediatrician Dana ...
... citizen,soared over the 13,500-foot peaks of Utah,s Uinta Mountains in ... II B-25 pilot Roy,Heden. The thrill came from a last-wish ... where Heden was a patient.,Called Go Wish, the program is ... realize a special activity at the end of their lives., ...
... self-care partly to blame , , FRIDAY, Oct. 10 (HealthDay News) ... being depressed was associated with a higher death rate, according ... October issue of the Journal of General Internal Medicine ... beneficiaries (average age of 75.6 years) who had diabetes and ...
... Healthcare Technology Evolution: Smarter Solutions for Better Patient Care ... ... 2008 -- The New Jersey and Delaware Valley Chapters of ... have joined forces to bring regional health information technology professionals ...
... ARBOR, Mich.---The University of Michigan received $5 million from ... leading resource of high-quality experimental data sets of drug-making ... a new level. , The resource will house ... predict the effectiveness of potential new drugs, said Heather ...
... (Nasdaq: ARAY ), a global leader in the ... for its first quarter fiscal,year 2009, ending September 27, ... A conference call to review the results will ... be hosted by Euan S. Thomson, Ph.D., president and,chief ...
Cached Medicine News:Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:U-M to house leading drug database 2Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2
Complete calibration kits are available for both pH and manometry systems....
... Calibration kit for convenient pH catheter calibration., ... to any procedure. The Alpine Calibration kit ... distilled water for your convenience. Simply cut ... your catheters to soak. No measuring or pouring! ...
Bravo Vacuum Pump. Complete with tubing....
Bravo pH capsule with delivery system....
Medicine Products: